The Genetic Frontier: Ethics and Innovation
Esta actividad de comprensión auditiva se divide en tres partes para poner a prueba tu nivel C1. Deberás responder a preguntas de opción múltiple, completar frases con palabras exactas del audio y resolver preguntas de análisis sobre el debate.
🔊
Part 1 — Conversation (questions 1–6)
| # |
Question |
Options |
| 1 |
What is the primary reason Speaker 1 feels unsettled by the article on CRISPR? |
The technology is too advanced to be understood. / The potential ethical implications are overwhelming. / The cost of the technology is too high. / The scientific community is moving too slowly. |
| 2 |
How does Speaker 2 describe the nature of biotechnology? |
As a tool that will definitely solve all human problems. / As a dangerous path that should be avoided entirely. / As a double-edged sword with both benefits and risks. / As a way to finally achieve social equality. |
| 3 |
What is Speaker 1's concern regarding 'designer babies'? |
That they will be too expensive for most families. / That the line between therapy and enhancement will blur. / That they will lead to a decrease in natural intelligence. / That parents will lose interest in natural children. |
| 4 |
According to Speaker 2, why is regulating biotechnology difficult? |
Because the technology changes too rapidly. / Because scientists refuse to follow the rules. / Because the governance is transnational in nature. / Because there is no consensus on what is ethical. |
| 5 |
What metaphor does Speaker 1 use to describe the current regulatory situation? |
A race where the rules are written mid-stride. / A storm that is approaching without warning. / A mountain that is too steep to climb. / A maze with no clear exit. |
| 6 |
What does Speaker 2 suggest is the defining debate of our century? |
The battle between science and religion. / The struggle to control global populations. / Balancing innovation with biological integrity. / The fight against environmental destruction. |
Part 2 — Monologue: sentence completion (questions 7–12)
Complete each sentence with 1–3 words from the recording.
1. The speaker describes the ethical implications of CRISPR as being...
2. Speaker 2 mentions the possibility of eradicating ... diseases.
3. Speaker 1 worries that selecting for certain traits could create a new kind of ...
4. The speaker describes the situation of preventing a child's suffering as a ...
5. The speaker notes that regulatory frameworks are not ... with technological leaps.
6. The speaker mentions the risk of setting off an irreversible ...
Part 3 — Panel discussion (questions 13–18)
13. What does the narrator mean by the shift in the 'paradigm' of biotechnology?
- We have moved from observing nature to actively rewriting it.
- We have transitioned from science to pure fiction.
- We have finally mastered the art of selective breeding.
- We have made biotechnology more accessible to the public.
14. How does modern technology differ from traditional selective breeding?
- It is much more expensive and less precise.
- It allows for real-time intervention rather than waiting for generations.
- It is focused solely on medicine rather than agriculture.
- It is much more predictable than natural selection.
15. What is the primary 'pro-biotech' argument mentioned in the monologue?
- The ability to create superior human beings.
- The economic benefits of new medical products.
- The moral imperative to alleviate human suffering.
- The necessity of staying ahead of other nations.
16. What is the main concern regarding 'germline editing'?
- It will be too difficult to implement in hospitals.
- Changes will be passed down to future generations.
- It will lead to an immediate population explosion.
- It is too expensive for developing nations.
17. What socio-economic risk does the narrator highlight?
- A world where biological advantages are reserved for the wealthy.
- The total collapse of the traditional healthcare system.
- A shortage of scientists due to ethical restrictions.
- The loss of jobs due to automated biotechnology.
18. How does Speaker 3 view the concept of germline editing?
- As a necessary step for human evolution.
- As a way to treat terminal illnesses effectively.
- As a fundamental alteration of human nature.
- As a manageable risk for future generations.
Vocabulario clave
- Staggering — Asombroso / Impactante 🔊
- Double-edged sword — Arma de doble filo 🔊
- Slippery slope — Pendiente resbaladiza / Situación peligrosa 🔊
- Moral conundrum — Dilema moral 🔊
- To keep pace — Mantener el ritmo / Seguir el paso 🔊
- To wrap one's head around — Lograr comprender algo complejo 🔊
- Paradigm shift — Cambio de paradigma 🔊
- To stifle — Sofocar / Frenar 🔊
Respuestas
Part 1: 1. A · 2. A · 3. A · 4. B · 5. A · 6. B
Part 2: 1. staggering · 2. hereditary · 3. social inequality · 4. moral conundrum · 5. keeping pace · 6. chain reaction
Part 3: 13. A · 14. A · 15. A · 16. C · 17. A · 18. A
Transcript
Ver transcript completo
SEGMENT 1 — CONVERSATION
Speaker 1: I was reading this fascinating article last night about CRISPR technology, and it honestly left me feeling a bit unsettled. It’s incredible how far we’ve come, but the ethical implications are just... well, they're staggering.
Speaker 2: I see where you're coming from. It is a bit of a double-edged sword, isn't it? On one hand, you have the potential to eradicate hereditary diseases that have plagued families for generations. On the other, you have this looming shadow of 'designer babies' and playing God. It’s a slippery slope, to say the least.
Speaker 1: Exactly! That’s precisely my concern. Once we start editing embryos to prevent certain conditions, where do we draw the line? It seems like a very thin veil between therapeutic intervention and mere cosmetic enhancement. If we start selecting for intelligence or athletic ability, aren't we essentially creating a new kind of social inequality?
Speaker 2: That’s a valid point, but I wonder if we shouldn't focus on the immediate life-saving potential first. I mean, if you could prevent a child from suffering a debilitating genetic disorder, wouldn't it be considered unethical *not* to intervene? It’s a moral conundrum, for sure.
Speaker 1: I suppose so, but the regulatory frameworks just don't seem to be keeping pace with the technological leaps. We're essentially running a marathon where the rules are being written while we're mid-stride.
Speaker 2: You're right there. The governance of biotechnology is notoriously difficult because it's so transnational. If one country imposes strict bans, researchers might just move to a jurisdiction with more laxer regulations. It's a bit of a regulatory nightmare, really.
Speaker 1: It really is. And let's not even get started on the long-term ecological consequences of gene drives or GMOs. We might be setting off a chain reaction that we can't possibly reverse.
Speaker 2: It’s certainly a lot to wrap one's head around. I think it’s going to be the defining debate of our century. We need to strike a balance between fostering innovation and ensuring we don't inadvertently compromise our own biological integrity.
SEGMENT 2 — MONOLOGUE
Narrator: Good afternoon, everyone. Today, we’re delving into a topic that sits at the very intersection of science, ethics, and the future of our species: the rapid advancement of biotechnology. Now, before we get bogged down in the technicalities, let's establish a baseline. Biotechnology, in its broadest sense, is the use of living organisms or their components to develop products that improve our lives. While this sounds benign, the advent of genetic engineering has shifted the paradigm from merely observing nature to actively rewriting it.
Narrator: For decades, we have been engaged in selective breeding—essentially, slow-motion genetic engineering. However, modern techniques like CRISPR-Cas9 have accelerated this process exponentially. We are no longer waiting for generations of natural selection; we are intervening in real-time. This capability brings with it an unprecedented level of precision, but it also introduces a host of existential questions. Is it purely a matter of scientific progress, or are we overstepping our bounds?
Narrator: One of the most significant areas of application is in medicine. The prospect of gene therapy—where faulty genes are replaced or repaired—is nothing short of revolutionary. We are looking at potential cures for cystic fibrosis, sickle cell anaemia, and perhaps even certain types of cancer. This is the 'pro-biotech' argument: that we have a moral imperative to alleviate human suffering through these tools.
Narrator: However, we must grapple with the concept of germline editing. This refers to changes made to reproductive cells, meaning any alterations made will be passed down to future generations. This is where the debate becomes truly heated. Critics argue that we cannot possibly foresee the long-term effects of such permanent changes to the human gene pool. There is also the profound issue of consent; how can we make decisions for future individuals who have no say in their own genetic makeup?
Narrator: Furthermore, there's the socio-economic dimension. If genetic enhancement becomes a commodity, we risk a future where biological advantages are reserved for the wealthy, potentially leading to a genetically stratified society. This isn't just science fiction anymore; it's a tangible risk. As we move forward, the challenge will be to develop robust international standards that encourage medical breakthroughs while safeguarding against the more dystopian possibilities. It is, quite literally, a matter of life and death.
SEGMENT 3 — PANEL DISCUSSION
Speaker 1: Welcome to our final panel on the ethics of biotechnology. We have three distinguished guests here to debate the implications of genetic engineering. Let's jump straight in. Speaker 2, you've been quite vocal about the necessity of progress.
Speaker 2: Well, I wouldn't say 'necessity' in a vacuum, but I do believe that stifling research due to fear is a mistake. We shouldn't let hypothetical fears prevent us from solving very real, very present human suffering. If we have the tools to cure a child of a terminal illness, to withhold that treatment because of 'what ifs' seems, to me, ethically questionable.
Speaker 3: I hear what you're saying, but I think you're oversimplifying the issue. It's not just about 'what ifs'; it's about the fundamental alteration of human nature. When we talk about germline editing, we aren't just treating a patient; we are altering the blueprint of humanity. Once that door is open, there's no closing it. We're talking about a permanent shift in our biological identity.
Speaker 1: That's a powerful point, Speaker 3. But Speaker 2, how do you respond to the concern regarding social inequality? If these technologies are expensive and accessible only to an elite few, doesn't that create a biological divide?
Speaker 2: It's a legitimate concern, certainly. Any transformative technology, from electricity to the internet, initially creates a gap. However, the goal of scientific advancement is usually to make these technologies more efficient and, eventually, more affordable. The solution isn't to ban the technology, but to work on equitable distribution and robust regulation.
Speaker 3: But regulation is often reactive, not proactive. By the time we realize the social or biological consequences of gene editing, it might be too late to reverse it. We're talking about a level of power that human institutions are historically quite poor at managing. We need a global moratorium on certain types of editing until we have a much clearer ethical consensus.
Speaker 1: A moratorium is a significant proposal. Speaker 2, do you think such a delay would be detrimental to medical progress?
Speaker 2: It could certainly slow things down, yes. But I'd argue that a controlled, deliberate pace is better than a reckless sprint. My point is that we shouldn't be paralyzed by fear, but we must be guided by caution. We need to distinguish between somatic editing—which affects only the individual—and germline editing.
Speaker 3: I agree that somatic editing is much easier to justify. But the line between 'therapy' and 'enhancement' is incredibly blurry. If we allow editing for health, how do we stop it from sliding into enhancement? It's an slippery slope that we are ill-equipped to navigate.
Speaker 1: It seems we are at a crossroads. Thank you all for this incredibly stimulating discussion. It's clear that while the potential is immense, the responsibility is even greater.
